Condition (MeSH)
Epilepsy, Partial, Motor
ClinicalTrials.gov lists 5 trials for Epilepsy, Partial, Motor or a narrower condition beneath it. SK Life Science, Inc. has the most among industry and government lead sponsors, with 2.
Search trials, drugs, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Trials per phase
5 of the 5 trials are tagged with Epilepsy, Partial, Motor itself; the rest are tagged with a narrower condition beneath it.
When did Epilepsy, Partial, Motor trials start? (4)
Shown in this order: most recent first, 1990 onwards. 2026 is partial: trials registered with a 2026 start date so far, not a full year.
Trials over time, by phase
- Phase 3
- Not applicable
Top of scale: 2
Trials registered with a start date in each year, 1990 onward, stacked by phase (complete years only; the current partial year is in the table's notes). The table below lists the same counts, most recent years first.
| Year | Trials started |
|---|---|
| 2024 | 1 |
| 2017 | 1 |
| 2014 | 1 |
| 2009 | 2 |
No forecast is made for this condition: it averages 0.2 trial starts a year over the five years to September, under the 5 a year the method needs.
Recruitment duration, a model prediction: 1 trial still running at the 2026-10-09 snapshot, fewer than the 5 needed for a median. Source: ClinicalTrials.gov / AACT (CTTI), public domain.
What phase are Epilepsy, Partial, Motor trials in? (2)
Shown in this order: phase order.
Show the trials by phase as a table
| Phase | Trials |
|---|---|
| Phase 3 | 3 |
| Not applicable | 2 |
How many Epilepsy, Partial, Motor trials are recruiting? (4)
Shown in this order: the order a trial moves through, from not yet recruiting to unknown.
| Status | Trials |
|---|---|
| Recruiting | 1 |
| Completed | 2 |
| Terminated | 1 |
| Unknown status | 1 |
Status as registered on ClinicalTrials.gov. Each trial is counted once.
Which lead sponsors run the most Epilepsy, Partial, Motor trials? (1)
Shown in this order: most trials first. Lead sponsors the registry classes as industry, NIH, US federal, other government or network. A hospital or university the registry files as government can appear here. Sponsors it classes as academic or other are shown on the full page, because that class cannot separate an institution from a named investigator.
| Sponsor | Trials |
|---|---|
| SK Life Science, Inc. | 2 |
Which publications cover Epilepsy, Partial, Motor? (6)
Shown in this order: major-topic papers first, then newest, then most linked to trials.
| Publication | Journal | Year | Major topic |
|---|---|---|---|
| Functional connectivity in human cortical motor system: a cortico-cortical evoked potential study. | Brain : a journal of neurology | 2007 | Yes |
| Antiepileptic effects of low-frequency repetitive transcranial magnetic stimulation by different stimulation durations and locations. | Clinical neurophysiology : official journal of the International Federation of Clinical Neurophysiology | 2007 | Yes |
| Lacosamide in status epilepticus: Systematic review of current evidence. | Epilepsia | 2017 | No |
| Monitoring neonatal seizures. | Seminars in fetal & neonatal medicine | 2013 | No |
| Repetitive transcranial magnetic stimulation decreases the number of seizures in patients with focal neocortical epilepsy. | Seizure | 2008 | No |
Showing 5 of 6 publications.
Not on this page
Not measured: delivery record.
Checked, with nothing recorded for this condition: serious adverse events in this condition's trials, prevalence, rare-disease identity, and sub-conditions in mesh.
Not computed for conditions with fewer than 10 trials: drugs tested.